checkAd

     524  0 Kommentare DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children - Seite 4


    +1 646-722-8822
    ewhite@centronpr.com

     

            Media Contacts, Europe
    Caroline Carmagnol, Alize RP - Relation Presse
    +33 (0)6 64 18 99 59
    caroline@alizerp.com              

    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: DBV Technologies via Globenewswire

    Lesen Sie auch

    HUG#2023219
    Seite 4 von 4




    GlobeNewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von GlobeNewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children - Seite 4 Press ReleaseMontrouge, France, June 27, 2016 DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children Company Expects to Report Topline Results for PEPITES in …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer